The building’s development is part of a five-year $7.8bn investment plan by Boehringer Ingelheim. As part of the investment, the company opened a biomass power plant in Ingelheim, Germany ...

Boehringer Ingelheim says it is on track to launch ... the company has now overtaken Bayer as the largest Germany-headquartered pharma group. For 2024, Boehringer said it expects a “slight ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...

Learn more at https://www.boehringer-ingelheim.com. This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business.

INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif., October 09, 2024--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...

Learn more at https://www.boehringer-ingelheim.com. This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business.

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, pledged USD 5 million to advance access to quality healthcare services for ...

Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a focus on vulnera ...

Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment: Ingelheim, Germany Friday, October 11, 2024, 12:00 Hrs [IST] Boehring ...